Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Moschini

Showing results (491-500 of 561) with videos related to

Pageof 57
Sort By:
European Urology Oncology|February 20, 2026
Real-world Adherence to European Association of Urology-recommended Non-muscle-invasive Bladder Cancer Management: From Evidence-based Practice to Oncological OutcomesMattia Longoni, Pietro Scilipoti, Mario De Angelis, et al.
Clinical Genitourinary Cancer|January 15, 2022
Contemporary Trends of Systemic Neoadjuvant and Adjuvant Intravesical Chemotherapy in Patients With Upper Tract Urothelial Carcinomas Undergoing Minimally Invasive or Open Radical Nephroureterectomy: Analysis of US Claims on Perioperative Outcomes and Health Care CostsFrancesco Del Giudice, Stefanie van Uem, Shufeng Li, et al.
BJU International|May 22, 2025
Contemporary outcomes in non-muscle-invasive bladder cancer: a large European multicentre studyMattia Longoni, Pietro Scilipoti, Mario De Angelis, et al.
Clinical Genitourinary Cancer|January 7, 2023
The Changing Face of cN0M0 Prostate Cancer Being Found With pN+ After Surgery in the Contemporary Era: Results of an International European Survey on Disease ManagementMatteo Sacco, Giorgio Gandaglia, Kirsti Aas, et al.
European Urology Oncology|June 21, 2024
Clinical Validation of the Intermediate-risk Non-muscle-invasive Bladder Cancer Scoring System and Substratification Model Proposed by the International Bladder Cancer Group: A Multicenter Young Academic Urologists Urothelial Working Group CollaborationFrancesco Soria, Matteo Rosazza, Simone Livoti, et al.
BJU International|January 11, 2025
Gemcitabine and docetaxel for high-risk non-muscle-invasive bladder cancer: EuroGemDoce group resultsPietro Scilipoti, Mattia Longoni, Mario de Angelis, et al.
World Journal of Urology|February 10, 2022
Carboplatin-based adjuvant chemotherapy versus observation after radical cystectomy in patients with pN1-3 urothelial bladder cancerLuca Afferi, Chiara Lonati, Francesco Montorsi, et al.
BJU International|May 6, 2019
Differences in trends in the use of robot-assisted and open radical cystectomy and changes over time in peri-operative outcomes among selected centres in North America and Europe: an international multicentre collaborationStefania Zamboni, Francesco Soria, Romain Mathieu, et al.
BJUI Compass|January 29, 2025
The impact of preoperative venous thromboembolism on patients undergoing TURBT: Perioperative outcomes and healthcare costs from US insurance claims dataAnas S Tresh, Francesco Del Giudice, Shufeng Li, et al.
World Journal of Urology|April 30, 2022
Neoadjuvant chemotherapy does not increase peri-operative morbidity following radical cystectomyAmandeep Arora, Ahmed S Zugail, Felipe Pugliesi, et al.
Pageof 57

Showing results (491-500 of 561) with videos related to

Sort By:
Pageof 57
European Urology Oncology|February 20, 2026
Real-world Adherence to European Association of Urology-recommended Non-muscle-invasive Bladder Cancer Management: From Evidence-based Practice to Oncological OutcomesMattia Longoni, Pietro Scilipoti, Mario De Angelis, et al.
Clinical Genitourinary Cancer|January 15, 2022
Contemporary Trends of Systemic Neoadjuvant and Adjuvant Intravesical Chemotherapy in Patients With Upper Tract Urothelial Carcinomas Undergoing Minimally Invasive or Open Radical Nephroureterectomy: Analysis of US Claims on Perioperative Outcomes and Health Care CostsFrancesco Del Giudice, Stefanie van Uem, Shufeng Li, et al.
BJU International|May 22, 2025
Contemporary outcomes in non-muscle-invasive bladder cancer: a large European multicentre studyMattia Longoni, Pietro Scilipoti, Mario De Angelis, et al.
Clinical Genitourinary Cancer|January 7, 2023
The Changing Face of cN0M0 Prostate Cancer Being Found With pN+ After Surgery in the Contemporary Era: Results of an International European Survey on Disease ManagementMatteo Sacco, Giorgio Gandaglia, Kirsti Aas, et al.
European Urology Oncology|June 21, 2024
Clinical Validation of the Intermediate-risk Non-muscle-invasive Bladder Cancer Scoring System and Substratification Model Proposed by the International Bladder Cancer Group: A Multicenter Young Academic Urologists Urothelial Working Group CollaborationFrancesco Soria, Matteo Rosazza, Simone Livoti, et al.
BJU International|January 11, 2025
Gemcitabine and docetaxel for high-risk non-muscle-invasive bladder cancer: EuroGemDoce group resultsPietro Scilipoti, Mattia Longoni, Mario de Angelis, et al.
World Journal of Urology|February 10, 2022
Carboplatin-based adjuvant chemotherapy versus observation after radical cystectomy in patients with pN1-3 urothelial bladder cancerLuca Afferi, Chiara Lonati, Francesco Montorsi, et al.
BJU International|May 6, 2019
Differences in trends in the use of robot-assisted and open radical cystectomy and changes over time in peri-operative outcomes among selected centres in North America and Europe: an international multicentre collaborationStefania Zamboni, Francesco Soria, Romain Mathieu, et al.
BJUI Compass|January 29, 2025
The impact of preoperative venous thromboembolism on patients undergoing TURBT: Perioperative outcomes and healthcare costs from US insurance claims dataAnas S Tresh, Francesco Del Giudice, Shufeng Li, et al.
World Journal of Urology|April 30, 2022
Neoadjuvant chemotherapy does not increase peri-operative morbidity following radical cystectomyAmandeep Arora, Ahmed S Zugail, Felipe Pugliesi, et al.
Pageof 57